Portland Hill Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$296K Hold
21,008
0.72% 17
2023
Q4
$205K Hold
21,008
0.54% 18
2023
Q3
$213K Hold
21,008
0.55% 19
2023
Q2
$158K Hold
21,008
0.37% 23
2023
Q1
$193K Hold
21,008
0.45% 20
2022
Q4
$195K Sell
21,008
-479
-2% -$4.45K 0.54% 21
2022
Q3
$196K Buy
21,487
+372
+2% +$3.39K 0.37% 26
2022
Q2
$158K Sell
21,115
-1,472
-7% -$11K 0.21% 30
2022
Q1
$212K Sell
22,587
-734
-3% -$6.89K 0.19% 28
2021
Q4
$187K Sell
23,321
-2,461
-10% -$19.7K 0.14% 29
2021
Q3
$251K Buy
25,782
+67
+0.3% +$652 0.17% 24
2021
Q2
$255K Hold
25,715
0.15% 23
2021
Q1
$296K Hold
25,715
0.2% 23
2020
Q4
$245K Hold
25,715
0.17% 22
2020
Q3
$234K Buy
25,715
+167
+0.7% +$1.52K 0.19% 22
2020
Q2
$310K Buy
25,548
+363
+1% +$4.41K 0.31% 20
2020
Q1
$235K Sell
25,185
-1,189
-5% -$11.1K 0.3% 20
2019
Q4
$262K Sell
26,374
-1,673
-6% -$16.6K 0.27% 17
2019
Q3
$190K Buy
28,047
+113
+0.4% +$766 0.15% 17
2019
Q2
$258K Sell
27,934
-3,241
-10% -$29.9K 0.19% 18
2019
Q1
$491K Sell
31,175
-1,944
-6% -$30.6K 0.35% 18
2018
Q4
$510K Sell
33,119
-2,551
-7% -$39.3K 0.35% 18
2018
Q3
$758K Sell
35,670
-760
-2% -$16.2K 0.33% 19
2018
Q2
$900K Sell
36,430
-6,590
-15% -$163K 0.38% 19
2018
Q1
$735K Buy
43,020
+3,073
+8% +$52.5K 0.32% 20
2017
Q4
$763K Buy
39,947
+8,690
+28% +$166K 0.35% 19
2017
Q3
$550K Sell
31,257
-3,109
-9% -$54.7K 0.27% 20
2017
Q2
$1.14M Sell
34,366
-1,228
-3% -$40.8K 0.58% 19
2017
Q1
$1.15M Sell
35,594
-602
-2% -$19.5K 0.6% 22
2016
Q4
$1.31M Buy
+36,196
New +$1.31M 0.79% 20